Researchers from the Terasaki Institute for Biomedical Innovation, together with key pioneers in glioma biology, neuro-oncology and stem cell biology, have published a comprehensive review in Society ...

ICSE board has released the official syllabus for classes 9 to 12 to help students prepare for the board exams. Students can ...

Deep learning variant calling has transformed genomic accuracy. Discover how DeepVariant works, outperforms classical tools, ...

Announcing a new article publication in BIO Integration. The authors of this article developed CellDeathAnalysis (v0.4.0), an ...

A noninvasive blood-based test identified cases of endometriosis that were missed by imaging, data at the Endocrine Society ...

IP portfolio to clinical-stage biopharmaceutical assetsXTL Biopharmaceuticals (XTL) Completes the Acquisition of Psyga Bio and ...

The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

Industry groups are asking the US Food and Drug Administration (FDA) for greater transparency into its Commissioner's National Priority Voucher (CNPV) pilot, including how the agency intends to ...

Anthropic’s new Claude research reveals a hidden internal “global workspace” that resembles human conscious processing, ...

One of the most detailed maps to date of meningioma -- the most common brain tumor in adults -- reveals how the tumor's ...

The court upheld state laws in West Virginia and Idaho barring the participation of transgender female athletes from girls’ ...

It might seem like semantics. But whether a health condition qualifies as a disease can have a huge impact on patient experiences and treatment options.